DV
Dividend Vision

FBIO — Fortress Biotech Inc

Fortress Biotech Inc (FBIO)

Total return is -98.2% over the past 14.7 years, 821.7 points behind SPY at 723.5%. Its deepest 1-year drawdown was 49.3%.

FBIO is an equity fund focused on the biotech sector that tracks Fortress Biotech Inc, a company operating in the biotechnology industry. The fund does not currently maintain a regular distribution schedule or stated dividend yield. The fund has been active since 2011 and may appeal to investors seeking exposure to biotech equities, though income-focused dividend investors would find limited yield characteristics here.

FBIO key facts

Asset type
Stock
Asset class
Equity
Inception date
11/17/2011
Last close
$2.93
Market cap
$111,616,080
Average volume
1029900.0
Beta
1.21
Payout ratio
0.0
P/E ratio
1.0402
Forward P/E
1.4021
EPS
$3.23